| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/18/2002 | CN1090954C 胃炎胶囊 Gastritis Capsules |
| 09/18/2002 | CN1090952C Medicine for treating hepatopostema and its prepn. method |
| 09/18/2002 | CN1090951C Traditional Chinese medicine for curing gastrointestinal disease |
| 09/18/2002 | CN1090950C Combined Chinese and western medicine for treating nevus and its prepn.method |
| 09/18/2002 | CN1090947C External application powder compsn. and cloth wetting agent |
| 09/18/2002 | CN1090945C Bone setting capsle and its preparing process |
| 09/18/2002 | CN1090943C Easy-to-store and-use compound royal jelly and its preparing method |
| 09/18/2002 | CN1090940C Medicinal powder for treating burn and scald |
| 09/18/2002 | CN1090938C Ointment contg. low-molecular heparm and its preparing method |
| 09/17/2002 | US6451994 Polypeptides, polynucleotides; drug screening; diagnosing alzheimer*s, parkinson*s, huntington*s, and creutzfelt-jacob disease; amyotrophic lateral sclerosis, cystic fibrosis |
| 09/17/2002 | US6451759 Noncleavable Fas ligand |
| 09/17/2002 | US6451594 Adenovirus vector comprising transgene, cardiomyocyte restricted ankyrin repeat protein promoter, and inverted terminal repeat sequences from human adeno-associated virus |
| 09/17/2002 | US6451592 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 09/17/2002 | US6451579 Regulated expression of recombinant proteins using RNA viruses |
| 09/17/2002 | US6451355 Composition to treat diabetes |
| 09/17/2002 | US6451352 Adminsitering sea water as antiinflammatory agent to mucous membranes of the respiratory tract |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451256 Recombinant viruses in frozen or liquid form, in which infectious viruses are preserved in an aqueous solution. the recombinant virus suspension comprises an aqueous sucrose solution at a concentration for gene therapy. |
| 09/17/2002 | US6451203 Blood processing systems and methods using apparent hematocrit as a process of control parameter |
| 09/17/2002 | US6451060 Chondrocyte cell culture; overcoating permselective membrane |
| 09/17/2002 | CA2260007C Method for treating gastrointestinal damage |
| 09/17/2002 | CA2223417C Method for the manufacture of minimal volume capsules containing biological material |
| 09/17/2002 | CA2213001C Isolated nucleic acid molecule encoding peptides which form complexes with mhc molecule hla-cw*1601 and uses thereof |
| 09/17/2002 | CA2204151C Cdna encoding a bmp type ii receptor |
| 09/17/2002 | CA2113118C Novel growth factor-responsive progenitor cells which can be proliferated in vitro |
| 09/17/2002 | CA2072420C Storage of materials |
| 09/12/2002 | WO2002070748A2 Response of dendritic cells to a diverse set of pathogens |
| 09/12/2002 | WO2002070711A1 Vaccine |
| 09/12/2002 | WO2002070670A1 Novel lactobacillus reuteri useful as probiotics |
| 09/12/2002 | WO2002070655A2 Mouse cytokine receptor |
| 09/12/2002 | WO2002070594A2 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070556A1 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF |
| 09/12/2002 | WO2002070552A2 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF |
| 09/12/2002 | WO2002070549A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/12/2002 | WO2002070023A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation |
| 09/12/2002 | WO2002070006A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/12/2002 | WO2002070004A2 Papillomavirus vaccines |
| 09/12/2002 | WO2002069997A1 Modified protamine with reduced immunogenicity |
| 09/12/2002 | WO2002069991A1 Bacterial translocation inhibitor and method of inhibiting bacterial translocation |
| 09/12/2002 | WO2002069990A1 Method of treating tumor and consignment system of proliferating and processing activated lymphocytes to be used in parallel to pdt |
| 09/12/2002 | WO2002069989A2 Aquatic animal treatment method and composition containing pimenta extract |
| 09/12/2002 | WO2002069988A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 09/12/2002 | WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof |
| 09/12/2002 | WO2002069799A1 Method of predicting stroke evolution utilising mri |
| 09/12/2002 | WO2002069793A2 Extracorporeal blood processing information management system |
| 09/12/2002 | WO2002051986A3 Educated nk t cells and their uses in the treatment of immune-related disorders |
| 09/12/2002 | WO2002040640A3 Methods of using cd8+/tcr- facilitating cells (fc) for the engraftment of purified hematopoietic stem cells (hsc) |
| 09/12/2002 | WO2002028997A3 Methods of isolating bipotent hepatic progenitor cells |
| 09/12/2002 | WO2002022680A3 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 09/12/2002 | WO2002018605A3 Anti-microbial agents |
| 09/12/2002 | WO2002010351A3 Autologous connective tissues, methods for the production thereof and their use |
| 09/12/2002 | WO2002007748A3 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 09/12/2002 | WO2001091766A3 Compositions for treating hand and wrist discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 09/12/2002 | WO2001046384A3 A method for isolating and purifying multipotential neural progenitor cells and multipotential neural progenitor cells |
| 09/12/2002 | WO2001045722A9 Somnogenic activity of non-pathogenic lactic acid bacteria |
| 09/12/2002 | WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof |
| 09/12/2002 | WO2001013933A9 Agents for the enhanced oxygen delivery in mammals |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | US20020129398 Transfection, storage and transfer of male germ cells for generation of trangenic species |
| 09/12/2002 | US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis |
| 09/12/2002 | US20020128711 Acellular matrix grafts: preparation and use |
| 09/12/2002 | US20020128453 Generating immunoglobulin; obtain blood sample, incubate with pepsin, remove decomposed products, recover immunoglobulins |
| 09/12/2002 | US20020128346 Cell growth substrate polymer that is obtainable by copolymerizing a sulfo-containing monomer with a nonsulfo-containing monomer, optionally with a photoinitiator; especially photopolymerizing |
| 09/12/2002 | US20020128313 Administering to the herd native or extended semen with a simultaneous or sequential administration of prostaglandin |
| 09/12/2002 | US20020128304 Administering as anticarcinogenic agent |
| 09/12/2002 | US20020128256 Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation |
| 09/12/2002 | US20020128207 Dried blood factor composition comprising trehalose |
| 09/12/2002 | US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals |
| 09/12/2002 | US20020128182 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 09/12/2002 | US20020127719 Xenograft heart valves |
| 09/12/2002 | US20020127717 Preparation of replicating macrophages and use in diagnosis and therapy |
| 09/12/2002 | US20020127716 Isolating preferential cells for use in the treatment of nervous system damage; isolate preferential cells, incubate with animal growth regulators, propagate, recover cells |
| 09/12/2002 | US20020127715 Adjusting gene expression in preferential cells; obtain pluripotent cells, transform, monitor gene expression, compare to control, detect adjustment in gene expression |
| 09/12/2002 | US20020127713 Specific tolerance in transplantation |
| 09/12/2002 | US20020127711 Process for ex vivo formation of mammalian bone and uses thereof |
| 09/12/2002 | US20020127700 Methods for improved diagnosis and treatment of mycobacterial infections |
| 09/12/2002 | US20020127694 2786, a novel human aminopeptidase |
| 09/12/2002 | US20020127682 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 09/12/2002 | US20020127681 Enzymatic protein for use in treatment of diarrhea |
| 09/12/2002 | US20020127616 Prenatal diagnostic methods |
| 09/12/2002 | US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors |
| 09/12/2002 | US20020127558 Genetic polymorphism of MxA protein and use thereof |
| 09/12/2002 | US20020127279 Contacting colostral whey with one or more filters, at least one of one or more filters having an average pore size of no more than 50 nm, whey encountering a pressure during the contacting step of no more than 200 kPa |
| 09/12/2002 | US20020127246 Use of herpes vectors for tumor therapy |
| 09/12/2002 | US20020127236 Contacting the sample containing an antibody specific for isolated and purified antigenically-active blood group antigen protein or peptide to allow the formation of an immune complex; and detecting the immune complex |
| 09/12/2002 | US20020127211 Increasing or facilitating absorption of minerals from diet using enteral nutritional composition which includes lactobacilli |
| 09/12/2002 | US20020127210 Transplants for myocardial scars |
| 09/12/2002 | US20020127208 Method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease |
| 09/12/2002 | US20020127207 Compositions and methods for reducing the amount of salmonella in livestock |
| 09/12/2002 | US20020127205 Immunoregulatory molecule expressed by the cell(s) are capable of inhibiting T cell activation and/or natural killer cell-mediated immune response against the cell upon transplantation into a recipient subject |
| 09/12/2002 | US20020124526 Albumin in a flexible polymeric container |
| 09/12/2002 | DE10208678A1 Polyurethane foam product for cosmetic or dermatological use comprises the in situ reaction product of a urethane prepolymer with an aqueous dispersion containing selected active ingredients |
| 09/12/2002 | DE10112360A1 Transformierte Blutzellen und ihre Verwendung zum Wirkstoffscreening Transformed blood cells and their use for drug screening |